| Axon ID |
Name |
Description |
From price |
|
1136
|
SU 6656
|
SRC kinase inhibitor |
€120.00 |
|
1392
|
Dasatinib
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€90.00 |
|
1407
|
SKI 606
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€75.00 |
|
1416
|
NVP-TAE684
|
NPM-ALK inhibitor |
€50.00 |
|
1419
|
AB 1010
|
PDGFR, c-KIT and FGFR3 tyrosine kinase inhibitor |
€70.00 |
|
1456
|
AZD0530 difumarate
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
1540
|
VX 680
|
Aurora inhibitor (non-specific) |
€60.00 |
|
1541
|
ZM 447439
|
Aurora B inhibitor |
€85.00 |
|
1580
|
AZD1152-HQPA
|
Aurora B inhibitor |
€70.00 |
|
1597
|
Aurora A inhibitor I
|
Aurora A inhibitor |
€125.00 |
|
1630
|
Aurora A inhibitor II
|
Aurora A inhibitor |
€125.00 |
|
1660
|
Crizotinib
|
c-MET Inhibitor; NPM-ALK inhibitor |
€70.00 |
|
1673
|
PD173074
|
FGFR1 and FGFR3 inhibitor |
€75.00 |
|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€140.00 |
|
1702
|
OSI 906
|
IGF1R tyrosine kinase inhibitor |
€60.00 |
|
1763
|
CoPo 22
|
Modulator of CFTR (δ-F508 Selective) |
€120.00 |
|
1775
|
NVP-BGJ398
|
Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 |
€80.00 |
|
1836
|
CCT 137690
|
Aurora inhibitor (non-specific) |
€115.00 |
|
1891
|
SU 6668
|
Inhibitor of RTK targeting PDGFR, VEGF and FGFR |
€100.00 |
|
1917
|
AZD4547
|
Potent and selective FGFR inhibitor |
€85.00 |
|
1941
|
MLR 1023
|
Selective allosteric activator of Lyn kinase |
€95.00 |
|
1942
|
E 3810 dihydrochloride
|
Dual VEGFR/FGFR tyrosine kinase inhibitor |
€90.00 |
|
1961
|
MK 5108
|
Inhibitor of Aurora A kinase |
€110.00 |
|
1981
|
LY 2874455
|
Potent and selective FGFR inhibitor |
€110.00 |
|
2003
|
MLN8237
|
Second generation selective Aurora A inhibitor |
€90.00 |
|
2005
|
ASP 3026
|
Inhibitor of the oncogenic fusion kinase EML4-ALK |
€80.00 |
|
2023
|
PF 03814735
|
ATP-competitive inhibitor of aurora kinase A and B |
€120.00 |
|
2096
|
Hesperadin
|
Reversible and ATP-competitive inhibitor of Aurora B |
€95.00 |
|
2097
|
CGP 77675
|
Src Family kinase (SFK) inhibitor |
€65.00 |
|
2098
|
PD161570
|
Selective FGFR1 inhibitor |
€75.00 |
|
2153
|
AZD3463
|
Potent inhibitor of ALK and IGF1R |
€105.00 |
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
€85.00 |
|
2234
|
SSR 128129E
|
Allosteric inhibitor of FGF receptor signaling |
€110.00 |
|
1892
|
1-NM-PP1
|
Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) |
€95.00 |
|
2238
|
NT 157
|
Unique allosteric inhibitor of IGF1R signaling |
€95.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2267
|
GSK 1838705A
|
Potent IGF-IR and insulin receptor (IR) kinase inhibitor with additional affinity for ALK |
€110.00 |
|
2129
|
Stem Cell 3i inhibitor Set
|
Set of FGFR inhibitor SU5402 (Axon 1667), MEK inhibitor PD184352 (Axon 1368) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€130.00 |
|
2130
|
Stem Cell Alternative 2i inhibitor Set
|
Set of SRC inhibitor CGP77675 (Axon 2097) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€110.00 |
|
5006
|
Stem Cell CSD inhibitor Set
|
Set of CHIR99021, SU5402, and DAPT, inhibitors of GSK-3, FGFR, and γ-secretase, resp. |
€140.00 |
|
5007
|
Stem Cell 5i inhibitor Set
|
Set of five inhibitors for neural differentiation of human pluripotent stem cells. |
€200.00 |
|
2381
|
WH-4-023
|
Orally active src-family selective lck inhibitor |
€90.00 |
|
2294
|
KRCA 0008
|
Potent and selective dual ALK/ACK1 inhibitor with good drug-like properties |
€95.00 |
|
1944
|
NVP-BGJ398 phosphate
|
Inhibitor of FGFR tyrosine kinases 1, 2 ,3 and 4 |
€90.00 |
|
5011
|
Naive Stem Cell 5i inhibitor Set
|
Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency |
€200.00 |
|
2648
|
Nintedanib
|
RTK inhibitor with antiangiogenic and antineoplastic activities |
€70.00 |
|
2778
|
Squarunkin A
|
Selective UNC119–cargo interaction inhibitor |
€125.00 |
|
2906
|
SNS 314 mesylate
|
Potent and selective Aurora inhibitor (non-specific) |
€90.00 |
|
2930
|
Alofanib
|
Allosteric inhibitor of FGFR2 |
€90.00 |
|
2953
|
Roblitinib
|
First-in-class, highly selective and potent FGFR4 inhibitor |
€125.00 |
|
2978
|
Brigatinib
|
Potent, selective, and orally active anaplastic lymphoma kinase (ALK) inhibitor |
€80.00 |
|
3284
|
Saracatinib
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
3165
|
Lenvatinib
|
Multi-targeted receptor tyrosine kinase inhibitor |
€70.00 |
|
3270
|
Lj-1-60
|
Fyn inhibitor targeting the Fyn/Stat3 pathway |
€90.00 |
|
3408
|
AKI603
|
Inhibitor of Aurora A kinase |
€145.00 |
|
3341
|
PQ401
|
Potent IGF1R tyrosine kinase inhibitor |
€100.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3758
|
LY-3295668
|
Orally available, potent and highly selective Aurora A kinase (AurA) inhibitor |
Inquire |
|
3830
|
GSK1904529A
|
Potent, selective and orally active inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) |
Inquire |
|
3866
|
TAE226
|
Potent and ATP-competitive dual FAK and IGF-1R inhibitor |
€110.00 |
|
3920
|
GSK1070916
|
Potent, selective and ATP competitive inhibitor of Aurora B and C kinases |
€110.00 |
|
3931
|
CEP-28122
|
Highly potent, selective and orally active ALK inhibitor |
Inquire |
|
4038
|
CEP-37440 hydrochloride
|
Potent, selective and orally active inhibitor of ALK anf FAK |
Recently added
|
Inquire |